Cleveland Clinic sells AI spinoff to digital health startup

Recuro has acquired MyLegacy, a clinical decision-making support application, which was developed by the Cleveland Clinic Genomic Medicine Institute.

Advertisement

Three things to know:

  1. MyLegacy will allow the startup to pair automated genetic data gathering with care planning to save time and make more precise decisions, according to a June 22 news release.

  2. “This acquisition further increases the scope and capabilities of Recuro’s digital health platform, pairing automated genetic data gathering with complex care planning to save time, make care more precise and streamline the full continuum of care,” the release said.
  3. It is unclear how much Cleveland Clinic sold MyLegacy for.

Becker’s 3rd Annual Fall Chief Pharmacy Officer Summit is the top tier event that the people leading the future of pharmacy convene. This 3-day event is built specifically for Chief Pharmacy Officers and senior pharmacy leaders. The sessions examine the workforce, financial and clinical priorities shaping pharmacy today. Becker’s is where candid discussions flourish and new ideas thrive. Becker's 3rd Annual Fall Chief Pharmacy Officer Summit

Advertisement

Next Up in Digital Health

Advertisement

Comments are closed.